CNO Financial Group (CNO) Stock: Buy, Sell, or Hold?
CNO - CNO Financial Group, Inc.
$53.85
0.77 (1.45%)
▲
5d:
-0.24%
30d:
-2.66%
90d:
+2.3%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 02, 2026
30d
Get Alerted When CNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNO is fairly valued with market pricing in 2.7% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CNO is fairly valued with market pricing in 2.7% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$65.45
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$40.64
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNO is currently trading at $53.85, which is considered slightly low relative to its 30-day fair value range of $53.74 to $55.64. The stock's valuation (Forward PE: 10.6) is in line with its historical norms (9.8). At these levels, the market is pricing in 2.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNO is in a strong uptrend. Immediate support is located at $51.94, while resistance sits at $56.13.
Market Sentiment: CNO scores 76/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNO is in a strong uptrend. Immediate support is located at $51.94, while resistance sits at $56.13.
Market Sentiment: CNO scores 76/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$53.74 -
$55.64
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (76/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.75)
- NEUTRAL: Market pricing in 2.7% annual earnings growth - fairly valued
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$53.74 -
$55.64
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$51.94
Resistance Level
$56.13
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.56
Wall Street Target
$53.75
(+1.3%)
Revenue Growth (YoY)
11.6%
Earnings Growth (YoY)
46.2%
Profit Margin
6.0%
Valuation Premium vs History
+2.7% premium
PE vs Historical
10.6 vs 9.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.7%
(market-implied from PE analysis)
1-Year Target
$54.51
(+3%)
2-Year Target
$55.99
(+6%)
3-Year Target
$57.50
(+8%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$53.37
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 7.7%)
$128.01
(+141%)
Base:
(SPY PE: 10.6, Growth: 7.7%)
$66.25
(+25%)
Bear:
(PE: 9.0, Growth: 7.7%)
$56.31
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 18.24 | Current EPS (TTM): $2.90
Bull Case
$100.91
(+90%)
Analyst growth 73.4%, PE expands to 20.1
Base Case
$91.73
(+73%)
Market implied 73.4%, PE stable at 18.2
Bear Case
$35.98
(-32%)
Severe decline -20.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 3:34 PM ET
Data refreshes hourly during market hours. Next update: 4:34 PM
Data refreshes hourly during market hours. Next update: 4:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$106 | 53 HOLD |
|
UNM
Unum Group |
BUY
13 analysts |
$102 | 54 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 65 BUY |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$34 | 45 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
